Showing results (11-20 of 134) with videos related to
Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
"Vertical" Inhibition of HER2 Yields Horizontal Gains in the ClinicGeorge W Sledge, Mark D PegramInvestigational New Drugs|September 1, 2005
Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancerChristina H Yeon, Mark D PegramOncology (Williston Park, N.Y.)|February 3, 2005
Gemcitabine in combination with trastuzumab and/or platinum salts in breast cancer cells with HER2 overexpressionGottfried E Konecny, Mark D PegramClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2010
p27: a barometer of signaling deregulation and potential predictor of response to targeted therapiesSeth A Wander, Dekuang Zhao, Joyce M SlingerlandJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2017
Blocking the Cycle: Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic, Hormone Receptor-Positive Breast CancerSeth A Wander, Erica L Mayer, Harold J BursteinCell Cycle (Georgetown, Tex.)|October 16, 2009
p27 as Jekyll and Hyde: regulation of cell cycle and cell motilityMichelle D Larrea, Seth A Wander, Joyce M SlingerlandThe Journal of Clinical Investigation|April 15, 2011
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategySeth A Wander, Bryan T Hennessy, Joyce M SlingerlandTherapeutic Advances in Hematology|June 3, 2014
The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyondSeth A Wander, Mark J Levis, Amir T FathiClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2025
Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast CancerMaxwell R Lloyd, Caroline M Weipert, Azka Ali, et al.Expert Opinion on Biological Therapy|August 1, 2019
Induced pluripotent stem cells as a novel cancer vaccineLin Wang, Mark D Pegram, Joseph C WuPageof 14